PATENT CLAIM ANALYSIS

Application Number: 16035964
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "175100"]

Abstract:
The disclosure generally provides antibodies and antigen binding fragments of antibodies that bind ticagrelor and metabolites of ticagrelor. The disclosure also provides compositions comprising the antibodies, nucleic acid molecules encoding the antibodies, methods of treating a patient comprising administering the antibodies, and methods of making and using the antibodies.

Claim (Index 64):
The antibody or a fragment thereof of  claim 58 , wherein the antibody or a fragment thereof binds ticagrelor or an active metabolite thereof with an equilibrium K D  of about 50 nM or lower.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 95.0
- Lexical Diversity: 1.74194
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14871111', '14890653', '13820278', '15538510', '15516115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7193289104728485
- 35 USC 102 Novelty (BERT): 0.6128520218896448
- Combined Prediction Score: 0.7086812216145282
- Mean Citation Score: 416.906382
- Max Citation Score: 649.1163
- Similarity Product: 445.7416544413449

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test